Total Payments
$8,882
2024 Payments
$909.79
Companies
37
Transactions
336
Medicare Patients
5,314
Medicare Billing
$346,621
Payment Breakdown by Category
Food & Beverage$8,581 (96.6%)
Other$301.44 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,581 | 332 | 96.6% |
| Entertainment | $301.44 | 4 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,127 | 45 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,057 | 66 | $0 (2024) |
| ABBVIE INC. | $864.71 | 41 | $0 (2024) |
| Optos, Inc. | $781.00 | 11 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $639.44 | 28 | $0 (2023) |
| Shire North American Group Inc | $608.41 | 22 | $0 (2019) |
| Alcon Vision LLC | $588.37 | 15 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $393.70 | 9 | $0 (2021) |
| EYEVANCE PHARMACEUTICALS LLC | $322.89 | 13 | $0 (2022) |
| Alcon Laboratories Inc | $229.75 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $909.79 | 35 | ABBVIE INC. ($296.35) |
| 2023 | $1,124 | 53 | Sun Pharmaceutical Industries Inc. ($368.01) |
| 2022 | $1,190 | 47 | ABBVIE INC. ($323.74) |
| 2021 | $1,205 | 52 | Aerie Pharmaceuticals, Inc. ($217.97) |
| 2020 | $1,102 | 40 | Optos, Inc. ($240.04) |
| 2019 | $1,207 | 44 | Shire North American Group Inc ($235.18) |
| 2018 | $1,075 | 32 | Allergan Inc. ($292.92) |
| 2017 | $1,069 | 33 | Optos, Inc. ($256.52) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $14.88 | General |
| 12/20/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $39.21 | General |
| Category: Glaucoma | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: EYE CARE | ||||||
| 11/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: EYE CARE | ||||||
| 11/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $36.47 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/31/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 10/22/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Ophthalmology | ||||||
| 10/21/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/08/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: OPTOMETRY | ||||||
| 09/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: EYE CARE | ||||||
| 09/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: EYE CARE | ||||||
| 09/17/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| 09/16/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: OPTOMETRY | ||||||
| 08/27/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: EYE CARE | ||||||
| 08/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Dry eyes | ||||||
| 08/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: EYE CARE | ||||||
| 08/06/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Ophthalmology | ||||||
| 07/25/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $36.50 | General |
| Category: Ophthalmology | ||||||
| 06/28/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: EYE CARE | ||||||
| 06/10/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: EYE CARE | ||||||
| 06/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Ophthalmology | ||||||
| 05/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,460 | 2,069 | $472,541 | $93,372 |
| 2022 | 14 | 1,509 | 2,167 | $486,757 | $93,172 |
| 2021 | 14 | 1,350 | 1,878 | $420,439 | $91,749 |
| 2020 | 12 | 995 | 1,456 | $299,428 | $68,327 |
Total Patients
5,314
Total Services
7,570
Medicare Billing
$346,621
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 209 | 379 | $102,330 | $23,501 | 23.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 210 | 221 | $85,085 | $18,579 | 21.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 155 | 155 | $70,525 | $13,673 | 19.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 201 | 593 | $71,996 | $10,850 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $38,610 | $7,434 | 19.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 125 | 131 | $26,200 | $5,820 | 22.2% |
| 92250 | Photography of the retina | Office | 2023 | 126 | 128 | $27,520 | $3,267 | 11.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 128 | 131 | $17,685 | $3,243 | 18.3% |
| 92134 | Imaging of retina | Office | 2023 | 87 | 101 | $14,140 | $2,742 | 19.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 66 | 67 | $5,695 | $1,466 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $3,840 | $1,209 | 31.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 14 | 14 | $3,640 | $670.70 | 18.4% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2023 | 12 | 22 | $3,425 | $619.53 | 18.1% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 37 | 37 | $1,850 | $298.84 | 16.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 226 | 396 | $104,220 | $22,670 | 21.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 190 | 208 | $78,640 | $16,541 | 21.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 143 | 143 | $63,895 | $12,371 | 19.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 232 | 673 | $81,213 | $12,074 | 14.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 130 | 130 | $64,350 | $11,432 | 17.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 124 | 131 | $26,200 | $5,651 | 21.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 157 | 166 | $22,410 | $3,964 | 17.7% |
| 92134 | Imaging of retina | Office | 2022 | 87 | 97 | $13,580 | $2,631 | 19.4% |
| 92250 | Photography of the retina | Office | 2022 | 65 | 65 | $13,975 | $1,528 | 10.9% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 69 | 70 | $5,950 | $1,446 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $4,160 | $1,090 | 26.2% |
About Dr. Christopher Allee, O.D
Dr. Christopher Allee, O.D is a Optometrist healthcare provider based in Bellaire, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154324408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Allee, O.D has received a total of $8,882 in payments from pharmaceutical and medical device companies, with $909.79 received in 2024. These payments were reported across 336 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,581).
As a Medicare-enrolled provider, Allee has provided services to 5,314 Medicare beneficiaries, totaling 7,570 services with total Medicare billing of $346,621. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Bellaire, TX
- Active Since 05/31/2005
- Last Updated 03/31/2015
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1154324408
Products in Payments
- XIIDRA (Drug) $1,174
- LUMIGAN (Drug) $745.41
- Cequa (Drug) $647.24
- RESTASIS (Drug) $378.52
- VUITY (Drug) $375.40
- P200DTx (Device) $284.96
- AcrySof (Device) $261.95
- California (Device) $256.52
- Monaco (Device) $239.52
- CEQUA (Drug) $213.49
- Clareon (Device) $210.86
- INVELTYS (Drug) $206.90
- rocklatan (Drug) $192.47
- Flarex (Drug) $160.31
- Zerviate (Drug) $147.87
- RESTASIS MULTIDOSE (Drug) $139.01
- RXSIGHT CONTACT LENS (Device) $132.08
- TYRVAYA (Drug) $126.78
- Rhopressa (Drug) $125.63
- XELPROS (Drug) $124.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Bellaire
Dr. Jill Autry, O.d, O.D
Optometrist — Payments: $231,640
Optometrist $231,640
Aamena Kazmi, O.d, O.D
Optometrist — Payments: $13,333
Optometrist $13,333
Amanda Bachman, O.d, O.D
Optometrist — Payments: $8,761
Optometrist $8,761
Darcy Seaton, Od, OD
Optometrist — Payments: $8,403
Optometrist $8,403
Christopher Sek, Od, OD
Optometrist — Payments: $7,515
Optometrist $7,515
Julie Ngo, O.d, O.D
Optometrist — Payments: $7,330
Optometrist $7,330